Researchers have discovered that a drug currently being developed to treat stroke patients could also prevent Alzheimer’s disease. The study shows that the genetically engineered protein 3K3A-APC protects the brains of mice with Alzheimer’s-like symptoms, reducing the buildup of toxic peptides and preventing memory loss.
